Explain this page
Arphra AIPlain-English read on Boston Scientific Corporation’s valuationNext report
upcomingNo forward estimate on file.
Beat streak
0
consecutive EPS beats
Avg surprise
—
trailing 0q
EPS · actual vs estimate
· earnings_historyactualestimate
No earnings history on file.
Forward consensus
No forward annual estimates on file.
Revenue · actual vs estimate ($B)
No revenue estimate history on file.
Reports tracked
24
Beat rate
0%
0 beats · 12 misses (last 12)
Next report
Jul 22, 2026
Est. EPS $0.84
Last report
Apr 22, 2026
Earnings surprises · history
DB · earnings_surprises100% beat2| Period end | Estimate EPS | Actual EPS | Surprise % | Outcome |
|---|---|---|---|---|
| Apr 22, 2026 | $0.79 | $0.80 | +1.52% | Beat |
| Feb 04, 2026 | $0.78 | $0.80 | +2.43% | Beat |
Surprise history (last 16 quarters)
No surprise data available.
Upcoming reports
| Date | EPS estimate | Revenue estimate |
|---|---|---|
| Jul 22, 2026 | $0.84 | $5.4B |
Earnings history
| Date | EPS · est | EPS · actual | Surprise | Revenue · est | Revenue · actual | Result |
|---|---|---|---|---|---|---|
| Apr 22, 2026 | $0.79 | — | — | $5.17B | — | — |
| Feb 04, 2026 | $0.78 | — | — | $5.28B | — | — |
| Oct 22, 2025 | $0.71 | — | — | $4.97B | — | — |
| Jul 23, 2025 | $0.72 | — | — | $4.89B | — | — |
| Apr 23, 2025 | $0.67 | — | — | $4.57B | — | — |
| Feb 05, 2025 | $0.66 | — | — | $4.42B | — | — |
| Oct 23, 2024 | $0.59 | — | — | $4.04B | — | — |
| Jul 24, 2024 | $0.58 | — | — | $4.03B | — | — |
| Apr 24, 2024 | $0.51 | — | — | $3.68B | — | — |
| Jan 31, 2024 | $0.51 | — | — | $3.59B | — | — |
| Oct 26, 2023 | $0.48 | — | — | $3.47B | — | — |
| Jul 27, 2023 | $0.49 | — | — | $3.5B | — | — |
| Apr 26, 2023 | $0.43 | — | — | $3.16B | — | — |
| Feb 01, 2023 | $0.47 | — | — | $3.24B | — | — |
| Oct 26, 2022 | $0.44 | — | — | $3.14B | — | — |
| Jul 27, 2022 | $0.42 | — | — | $3.22B | — | — |
Analyst estimates · annual
| Period | EPS · avg | Revenue · avg | # Analysts |
|---|---|---|---|
| No analyst estimates returned. | |||
Analyst estimates · quarterly
| Period | EPS · avg | Revenue · avg | # Analysts |
|---|---|---|---|
| No analyst estimates returned. | |||